Bioerodible sustained release drug delivery systems
US10300114B2 · kind B2 · utility
0Cited by
14References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 1, 2014 |
| Grant date | May 28, 2019 |
| Priority date | — |
| Expiry date | Jul 1, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K51/1217
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to sustained release drug delivery systems, medical devices incorporating said systems, and methods of use and manufacture thereof. The inventive systems feature bioerodible drug delivery devices that include biocompatible solid and biocompatible fluid compositions to achieve desired sustained release drug delivery.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.